We use cookies on our website to improve our service to you and for security purposes. By continuing to use our site without changing your browser cookie settings, you agree to our cookie policy and the use of cookies. <a href="/acr-policies" target="_self">See ACR Policies</a>

Cookie Banner

Share Your Feedback: Do you have any general feedback to share with ARP staff? We want to hear from you!

Share Feedback

Resources for Rheumatology Professionals

Resources for Rheumatology Professionals (Page Survey)

Share Your Feedback: What do you think of the My Content page? Do you have suggestions for things to add or change?

My Content

My Content Feedback

Looking to claim credit, update your profile, access journals, or renew your membership? <a href="https://my.rheumatology.org/accounttnc?rid=my_account">Log in to your My Account page.</a>

Home

Annual Meeting

Ultrasound Conferences

State-of-the-Art Clinical Symposium

Winter Rheumatology Symposium

Rheumatology Research Workshop

ACR Convergence Replay Webinar: More Than Skin Deep: What Rheumatologists Should Know About the Skin

ACR Convergence Replay Webinar: 2024 Updated ACR Guideline for the Diagnosis and Treatment of Lupus Nephritis

ACR Convergence Replay 2024 Controversies in Treating ANCA-Associated Vasculitis

ACR Convergence Replay 2024: One Day Virtual Event

Program Coordinators Conference

ACR/APLAR Research Exchange Program

The Training Rheum

ACR/ARP Access in Rheumatology Meeting

Coding Guidelines Workshop – Updates & Impacts

Pediatric Rheumatology Symposium

Division Directors Forum

ACR/EULAR Research Exchange Program

Educators Conference

ACR Convergence

Fellows in Training (FIT) at SOTA

Global Meet the Experts Webinar Series: Auto-Inflammatory Diseases

Global Meet the Experts Webinar Series: Lupus Nephritis

Meetings & Webinars

My Account

<h4>Advocacy Update from the ACR D.C. Office</h4>View highlights from the ACR advocacy team’s efforts to respond to recent executive orders and government actions, equipping you with the information you need in the coming weeks and months.

May 20, 2025This week, the White House released an executive order on drug pricing, seemingly reviving the 2020 Most Favored Nation (MFN) proposal. Additionally, House committees release draft budgets with policy wins and big concerns for the rheumatology community. Finally, the Association of American Medical Colleges (AAMC) released a report on grants terminated by NIH. Here we summarize what the data from that report says and the work of ACR’s Washington, D.C. team on these policies.

<h4>From the ACR D.C. Office </h4>February 19, 2025As ACR President, Carol A. Langford, MD, MHS, mentioned in her message to members earlier this month, the ACR is endeavoring to maintain ongoing communication with members in these rapidly changing times to ensure that you can continue to provide excellent care to your patients.To that end, we want to highlight ways that the ACR’s advocacy team is working to respond to recent executive orders and government actions and equip you with the information you need in the coming weeks and months.<ol><li>The ACR’s advocacy team is actively monitoring unilateral executive actions that are shifting the health policy landscape daily. The ACR’s team in Washington, D.C. will be providing regular updates summarizing the happenings in D.C. and what they mean for you and your patients.</li><li>ACR/ARP members are invited to join the ACR’s advocacy team on February 20 and February 27 at 11:00 AM ET via Zoom for office hours to learn more about our team’s efforts on behalf of you and your patients, ask questions about ACR advocacy, and find out how you can get involved from home. You will receive a confirmation email with video call information once your membership status has been verified by the ACR team. <a href="https://rheumatology-org.zoom.us/meeting/register/tZEvduCprzsuE9JYoVinqQbOfycMdE-7wJtF#/registration" target="_blank">Register for Office Hours &gt;</a></li><li>Additionally, you may continue to contact your lawmakers through the ACR's <a href="/contact-policymakers">Legislative Action Center</a>. The ACR maintains campaigns that emphasize the importance of data and evidence-based policy making as well as broad access to public health information and guidance to address the health needs of the U.S. population.</li></ol>As we continue to monitor these issues, please do not hesitate to reach out to <a href="mailto:advocacy@rheumatology.org">advocacy@rheumatology.org</a> with any questions or concerns.

<h4>New Resource: Understanding the New Medicare G2211 Code</h4>Download the ACR educational guide and frequently asked questions for the new Medicare-specific add on code G2211 which addresses the complexity inherent to office and outpatient evaluation and management services.&nbsp;<a class="link-btn" href="https://assets.contentstack.io/v3/assets/bltee37abb6b278ab2c/bltd4f53fedee8221bf/understanding-new-medicare-g2211-code.pdf" target="_blank" rel="noopener noreferrer">Download Guide</a>

May 22, 2025 – Advocates for Arthritis Recap, Federal Agency Meetings & More

May 8, 2025 – ACR Urges Congress to Support the Rheumatology Community & More

April 24, 2025 – Testimony on Biosimilars, Key Issues for Advocates for Arthritis & More

Clinical Tools & Guidelines

Clinical Practice Guidelines

Clinical Guidance

Clinical Tools

Criteria

Advocacy News